Spark Therapeutics

company

About

Spark Therapeutics is focused on the development of treatments for genetic diseases.

  • 501 - 1000

Details

Last Funding Type
Series A
Last Funding Money Raised
$50M
Industries
Biotechnology,Genetics,Medical,Therapeutics
Founded date
Jan 1, 2013
Number Of Employee
501 - 1000
Operating Status
Active

Spark Therapeutics is developing potentially curative, one-time gene therapy products to transform the lives of patients and re-imagine the treatment of debilitating diseases.

The founding team includes scientists who have led the advancement of gene therapy over the past two decades, establishing human proof of concept of the expression of gene therapy in the eye and liver.

Spark’s robust pipeline includes SPK-RPE65, a fully enrolled, pivotal Phase 3 program in blindness due to mutations in the RPE65 gene, SPK-CHM for the treatment of choroideremia, and SPK-FIX, a program for the potential treatment of hemophilia B through a global collaboration with Pfizer Inc., as well as preclinical programs to address neurodegenerative diseases and other retinal degenerative diseases and hematologic disorders.

Spark has rights to a proprietary manufacturing platform that has a track record supporting clinical studies across diverse therapeutic areas and routes of administration.

Spark’s expertise across research, clinical, regulatory and manufacturing builds on a legacy of innovation and excellence in gene therapy established by Spark’s team while at The Children’s Hospital of Philadelphia Center for Cellular and Molecular Therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Spark Therapeutics has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Oct 22, 2013 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 22, 2013 Series A $50M 1 The Children's Hospital of Philadelphia Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Spark Therapeutics is funded by 1 investors. The Children's Hospital of Philadelphia are the most recent investors.
Investor Name Lead Investor Funding Round
The Children's Hospital of Philadelphia Yes Series A